Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-24

FDA Approved: HYDROXYPROGESTERONE CAPROATE — Supplemental Application (AuroMedics Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for hydroxyprogesterone caproate filed by AuroMedics Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroxyprogesterone caproate (hydroxyprogesterone caproate)

Snippet

SUPPL AP for HYDROXYPROGESTERONE CAPROATE (HYDROXYPROGESTERONE CAPROATE)